A carregar...

Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson’s disease

The LRRK2 (leucine-rich repeat protein kinase-2) is mutated in a significant number of Parkinson’s disease patients, but little is known about its regulation and function. A common mutation changing Gly(2019) to serine enhances catalytic activity, suggesting that small-molecule inhibitors might have...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nichols, R. Jeremy, Dzamko, Nicolas, Hutti, Jessica E., Cantley, Lewis C., Deak, Maria, Moran, Jennifer, Bamborough, Paul, Reith, Alastair D., Alessi, Dario R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3759966/
https://ncbi.nlm.nih.gov/pubmed/19740074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BJ20091035
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!